Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: atorvastatin attending: chief complaint: dyspnea on exertion major surgical or invasive procedure: s/p aortic root emlargement/aortic valve replaceement(#21 tissue)mitral valve replacement(#25 porcine)coronary artery bypass graft x1(saphenous vein graft-posterior descending artery). history of present illness: 60 year old woman with history of aortic stenosis followed by serial echocardiograms. patient now with worsening dyspnea on exertion. refered for surgical evaluation past medical history: hypertensiom hypercholesterolemia severe aortic stenosis mild mitral stenosis osteopenia arthritis asthma breast papilloma depression psh: oopherectomy breast cyst excision c-section bilateral carpal tunnel release l trigger finger release social history: receptionist tobbaco: 30 pack year history/quit 30 years ago etoh: denies lives with husband family history: father died of sudden death @37 years old physical exam: t hr 69 bp 117/60 rr 18 o2sat ht 5'0" wt 227lbs gen nad neuro a&ox3, grossly intact heent perrl, supple-full rom, mmm chest cta bilat cor rrr 3/4 systolic murmur abdm soft, non tender, non distended, nlormal bowel sounds ext warm well perfused, no varicosities pertinent results: 12:46pm urine rbc-<1 wbc-1 bacteria-none yeast-none epi-2 12:46pm urine blood-neg nitrite-neg protein-neg glucose-neg ketone-neg bilirubin-neg urobilngn-neg ph-7.0 leuk-mod 12:46pm urine color-yellow appear-clear sp -1.015 09:42am hgb-12.4 calchct-37 09:42am glucose-108* lactate-1.3 na+-139 k+-3.2* cl--95* 05:31pm urea n-12 creat-0.6 chloride-112* total co2-20* 06:05am blood wbc-19.8* rbc-3.28* hgb-10.2* hct-30.0* mcv-91 mch-31.1 mchc-34.0 rdw-17.2* plt ct-250 06:05am blood plt ct-250 01:56am blood pt-13.3 ptt-27.2 inr(pt)-1.1 06:05am blood glucose-89 creat-0.7 na-138 k-4.3 cl-100 hco3-25 angap-17 ====================================== , f 60 radiology report chest (pa & lat) study date of 8:33 am final report chest radiograph indication: evaluation for pleural effusions or atelectasis. status post cabg. comparison: . findings: as compared to the previous radiograph, the size of the cardiac silhouette is unchanged. there is a newly appeared plate-like atelectasis at the level of the left lung hilus. there is unchanged retrocardiac atelectasis. blunting of the left costophrenic sinus suggests a minimal left-sided pleural effusion. in the right lung, there is minimal atelectasis at the bases of the right upper lobe. newly occurred focal parenchymal opacities suggesting pneumonia are not seen. no evidence of overhydration, no pneumothorax. dr. approved: tue 11:30 am ==================================== echocardiography report , (complete) done at 11:34:24 am final referring physician information , , status: inpatient dob: age (years): 60 f hgt (in): 60 bp (mm hg): 124/64 wgt (lb): 224 hr (bpm): 64 bsa (m2): 1.96 m2 indication: aortic stenosis, cad, mitral regurg. intraop management icd-9 codes: 786.05, 440.0, 424.1, 394.0, 394.1, 424.0 test information date/time: at 11:34 interpret md: , md test type: tee (complete) son: , md doppler: full doppler and color doppler test location: anesthesia west or cardiac contrast: none tech quality: adequate tape #: 2009aw2-: machine: 2 echocardiographic measurements results measurements normal range left ventricle - inferolateral thickness: *1.5 cm 0.6 - 1.1 cm left ventricle - diastolic dimension: 4.3 cm <= 5.6 cm left ventricle - systolic dimension: 3.6 cm left ventricle - fractional shortening: *0.16 >= 0.29 left ventricle - ejection fraction: 50% to 55% >= 55% aorta - annulus: 1.8 cm <= 3.0 cm aorta - sinus level: 2.6 cm <= 3.6 cm aorta - sinotubular ridge: 2.5 cm <= 3.0 cm aorta - ascending: 2.9 cm <= 3.4 cm aortic valve - peak velocity: *2.7 m/sec <= 2.0 m/sec aortic valve - peak gradient: *28 mm hg < 20 mm hg aortic valve - mean gradient: 15 mm hg aortic valve - valve area: *0.6 cm2 >= 3.0 cm2 mitral valve - peak velocity: 1.2 m/sec mitral valve - mean gradient: 4 mm hg mitral valve - pressure half time: 104 ms mitral valve - mva (p t): 2.1 cm2 findings left atrium: no spontaneous echo contrast is seen in the laa. right atrium/interatrial septum: a catheter or pacing wire is seen in the ra and extending into the rv. no asd by 2d or color doppler. left ventricle: moderate symmetric lvh. low normal lvef. right ventricle: normal rv chamber size and free wall motion. aorta: simple atheroma in descending aorta. aortic valve: three aortic valve leaflets. severely thickened/deformed aortic valve leaflets. critical as (area <0.8cm2). no ar. mitral valve: severely thickened/deformed mitral valve leaflets. severe mitral annular calcification. severe thickening of mitral valve chordae. calcified tips of papillary muscles. moderate valvular ms (mva 1.0-1.5cm2) severe (4+) mr. tricuspid valve: normal tricuspid valve leaflets with trivial tr. pulmonic valve/pulmonary artery: pulmonic valve not well seen. physiologic (normal) pr. pericardium: no pericardial effusion. general comments: a tee was performed in the location listed above. i certify i was present in compliance with hcfa regulations. the patient was under general anesthesia throughout the procedure. no tee related complications. results were conclusions prebypass no spontaneous echo contrast is seen in the left atrial appendage. no atrial septal defect is seen by 2d or color doppler. there is moderate symmetric left ventricular hypertrophy. overall left ventricular systolic function is low normal (lvef 50-55%). right ventricular chamber size and free wall motion are normal. there are simple atheroma in the descending thoracic aorta. there are three aortic valve leaflets. the aortic valve leaflets are severely thickened/deformed. there is critical aortic valve stenosis (valve area <0.8cm2). no aortic regurgitation is seen. the mitral valve leaflets are severely thickened/deformed. there is severe mitral annular calcification. there is severe thickening of the mitral valve chordae. there is moderate valvular mitral stenosis (area 1.0-1.5cm2). severe (4+) mitral regurgitation is seen. dr. was notified in person of the results during the surgery on at 1014. postbypass patient is on phenylephrine infusion. a tissue valve is seen in the aortic position, no perivalvular leaks are seen, max gradient 26, mean gradient 12. a tissue valve is seen in the mitral position, no perivalvular leaks are seen, max gradient 8, mean gradient 2. aortic contours are smooth after decannulation. lv ef is somewhat reduced after bypass, the infrolateral, lateral and anterolateral walls are hypokinetic in addition to being intravascular volume dehydrated. i certify that i was present for this procedure in compliance with hcfa regulations. electronically signed by , md, interpreting physician 09:57 ===================================== brief hospital course: ms was admitted to as a same day admit on . she was brought to the operating room for a scheduled avr/mvr/cabg at that time. please see or report for full details. in summary she had an aortic root enlargement, aortic valve replacement with #21 pericardial valve, mitral valve replacement with #25 porcine valve, coronary bypass graft x1 with reverse saphanous vein graft to posterior descending artery. her bypass time was 251 minutes with a xcoss clamp of 227 minutes. the patient tolerated the operation well and was transferred post operatively to the cardiac surgery icu on epinephrine and propofol infusions. the patient remained intubated overnight given her inotropic support. on pod1 she was weaned from the inotropes, on pod2 she was weaned from thre ventilator and extubated. her chest tubes were removed and she was transferred from the icu to the stepdown floor on pod3. once on the floor she had an uneventful post operative course. she was noted to have periods of intermittant atrial fibrillation for which was treated with beta blockers and amiodarone following which she converted to sinus rhythm. on pod 6 it was decided she was ready for discharge to rehabilitation at healthcare. medications on admission: kcl 20 qd amlopidine 10 qd prozac 40 qd advair 1 puff hctz 25 qd crestor 5 qd asa 81 qd coenzyme q 10 qd vitamin d 400 qd mvi 1 qd fish oil 1000 discharge medications: 1. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). 2. aspirin 81 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po daily (daily). 3. fluoxetine 20 mg capsule sig: two (2) capsule po daily (daily). 4. fluticasone-salmeterol 250-50 mcg/dose disk with device sig: one (1) puff inhalation (2 times a day). 5. rosuvastatin 5 mg tablet sig: one (1) tablet po daily (daily). 6. amiodarone 200 mg tablet sig: two (2) tablet po bid (2 times a day): 400mg x 1 wk then 400mg qd x1 wk then 200mg qd. 7. insulin lispro 100 unit/ml solution sig: sliding scale subcutaneous qac&hs. 8. bisacodyl 10 mg suppository sig: one (1) suppository rectal daily (daily) as needed for constipation. 9. magnesium hydroxide 400 mg/5 ml suspension sig: thirty (30) ml po hs (at bedtime) as needed for constipation. 10. ranitidine hcl 150 mg tablet sig: one (1) tablet po bid (2 times a day). 11. acetaminophen 325 mg tablet sig: two (2) tablet po q4h (every 4 hours) as needed for pain. 12. albuterol sulfate 2.5 mg /3 ml (0.083 %) solution for nebulization sig: one (1) neb inhalation q6h (every 6 hours). 13. ipratropium bromide 0.02 % solution sig: one (1) neb inhalation q6h (every 6 hours). 14. tramadol 50 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for pain. 15. metoprolol tartrate 25 mg tablet sig: 1.5 tablets po tid (3 times a day). 16. potassium chloride 10 meq capsule, sustained release sig: four (4) capsule, sustained release po bid (2 times a day). 17. cephalexin 500 mg capsule sig: one (1) capsule po q8h (every 8 hours) for 7 days. 18. furosemide 10 mg/ml solution sig: forty (40) mg injection (2 times a day) for 1 weeks: then convert to po dosing. discharge disposition: extended care facility: health care center discharge diagnosis: s/p aortic root emlargement/aortic valve replaceement(#21 tissue)mitral valve replacement(#25 porcine)coronary artery bypass graft x1(saphenous vein graft-posterior diagonal artery). pmh: hypertension, hyperlipide,ia, osteopenia, depression, arthritis, s/p bilateral carpal tunnel release, s/p oopherectomy, s/p c-section, s/p breast cyst excision, breast papilloma, asthma, s/p trigger finger release discharge condition: good discharge instructions: keep wounds clean and dry. ok to shower, no bathing or swimming. take all medication as prescribed. call for any fever, redness or drainage from wounds. no creams lotions or ointments to wounds. no lifting >10 pounds, no driving untill cleared by surgeon followup instructions: clinic in 2 weeks dr in weeks dr in weeks dr in 4 weeks md procedure: extracorporeal circulation auxiliary to open heart surgery (aorto)coronary bypass of one coronary artery open and other replacement of aortic valve with tissue graft open and other replacement of mitral valve with tissue graft repair of blood vessel with tissue patch graft diagnoses: other iatrogenic hypotension thrombocytopenia, unspecified anemia, unspecified coronary atherosclerosis of native coronary artery unspecified essential hypertension atrial fibrillation asthma, unspecified type, unspecified personal history of tobacco use depressive disorder, not elsewhere classified pulmonary collapse other and unspecified hyperlipidemia surgical operation with anastomosis, bypass, or graft, with natural or artificial tissues used as implant causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation mitral valve insufficiency and aortic valve stenosis disorder of bone and cartilage, unspecified arthropathy, unspecified, site unspecified edema 

Answer: The patient is high likely exposed to